- Previous Close
0.0260 - Open
0.0260 - Bid 0.0250 x --
- Ask 0.0260 x --
- Day's Range
0.0250 - 0.0260 - 52 Week Range
0.0190 - 0.0420 - Volume
1,568,500 - Avg. Volume
3,183,548 - Market Cap (intraday)
49.711M - Beta (5Y Monthly) 1.35
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date Feb 20, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Jun 7, 2023
- 1y Target Est
--
Jiutian Chemical Group Limited, an investment holding company, manufactures and sells chemical-based products in the People's Republic of China. The company offers dimethylformamide, which is used as a feedstock in the production of polyurethane, pharmaceutical, and agro chemical products, as well as an absorbing agent primarily in electronics, acrylic fibers, and pharmaceutical products; and methylamine, a basic organic chemical used in various areas, such as rocket propellants, lithium batteries, pesticides, medicines, synthetic fuels, rubber accelerators, solvents for making chemical fiber, surfactants, and basic raw materials for fuels and photographic materials. It also provides sodium hydrosulfite, a crystalline powder for use in water treatment, gas purification, cleaning, and stripping, as well as in the industrial processing of textiles, leather, foods, polymers, photography, and others; Dimethylacetamide, a dipolar aprotic solvent used for organic reactions and industrial applications; industrial and consumable carbon dioxide for use in aerated beverages, tobacco, and preserving vegetables; and industrial methanol. In addition, the company is involved in the sale of downstream products. Jiutian Chemical Group Limited was incorporated in 2004 and is based in Singapore.
www.jiutianchemical.com.sgRecent News: C8R.SI
View MorePerformance Overview: C8R.SI
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is STI Index (^STI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: C8R.SI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: C8R.SI
View MoreValuation Measures
Market Cap
49.71M
Enterprise Value
29.14M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.10
Price/Book (mrq)
0.43
Enterprise Value/Revenue
0.65
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-60.63%
Return on Assets (ttm)
-6.05%
Return on Equity (ttm)
-21.36%
Revenue (ttm)
243.76M
Net Income Avi to Common (ttm)
-147.8M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
515.93M
Total Debt/Equity (mrq)
46.81%
Levered Free Cash Flow (ttm)
-127.5M